How HIV takes advantage of the cytoskeleton in entry and replication

Viruses

Volumn 3, Issue 4, 2011, Pages 293-311

  Stolp, Bettina ^a   Fackler, Oliver T ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Actin cytoskeleton; Cofilin; Entry; HIV; Nef

Indexed keywords

F ACTIN; NEF PROTEIN; P21 ACTIVATED KINASE 2; VIRUS PROTEIN;

BYSTANDER EFFECT; CELL FUNCTION; CYTOSKELETON; ENDOCYTOSIS; HUMAN IMMUNODEFICIENCY VIRUS; LIFE CYCLE; LYMPHOCYTE FUNCTION; NONHUMAN; NUCLEAR EXPORT SIGNAL; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; VIRION; VIRUS ASSEMBLY; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS RELEASE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; CYTOSKELETON; HIV; HIV INFECTIONS; HUMANS; VIRUS INTERNALIZATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 79955664789     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3040293     Document Type: Review

References (119)

1. Pollard, T.D.; Cooper, J.A. Actin, a central player in cell shape and movement. Science 2009, 326, 1208-1212.
2. Chhabra, E.S.; Higgs, H.N. The many faces of actin: Matching assembly factors with cellular structures. Nat. Cell Biol. 2007, 9, 1110-1121.
3. Burkhardt, J.K.; Carrizosa, E.; Shaffer, M.H. The actin cytoskeleton in T cell activation. Ann. Rev. Immunol. 2008, 26, 233-259.
4. Permanyer, M.; Ballana, E.; Este, J.A. Endocytosis of HIV: Anything goes. Trends Microbiol. 2010, 18, 543-551.
5. Doms, R.W.; Trono, D. The plasma membrane as a combat zone in the HIV battlefield. Genes Dev. 2000, 14, 2677-2688.
6. Tardif, M.R.; Tremblay, M.J. Regulation of LFA-1 activity through cytoskeleton remodeling and signaling components modulates the efficiency of HIV type-1 entry in activated CD4+ T lymphocytes. J. Immunol. 2005, 175, 926-935.
7. Geijtenbeek, T.B.; Kwon, D.S.; Torensma, R.; van Vliet, S.J.; van Duijnhoven, G.C.; Middel, J.; Cornelissen, I.L.; Nottet, H.S.; KewalRamani, V.N.; Littman, D.R.; Figdor, C.G.; van Kooyk, Y. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000, 100, 587-597.
8. Crublet, E.; Andrieu, J.P.; Vives, R.R.; Lortat-Jacob, H. The HIV-1 envelope glycoprotein gp120 features four heparan sulfate binding domains, including the co-receptor binding site. J. Biol. Chem. 2008, 283, 15193-15200.
9. Melikyan, G.B. Common principles and intermediates of viral protein-mediated fusion: The HIV-1 paradigm. Retrovirology 2008, 5, 111.
10. Iyengar, S.; Hildreth, J.E.; Schwartz, D.H. Actin-dependent receptor colocalization required for human immunodeficiency virus entry into host cells. J. Virol. 1998, 72, 5251-5255.
11. Steffens, C.M.; Hope, T.J. Mobility of the human immunodeficiency virus (HIV) receptor CD4 and coreceptor CCR5 in living cells: Implications for HIV fusion and entry events. J. Virol. 2004, 78, 9573-9578.
12. Barrero-Villar, M.; Cabrero, J.R.; Gordon-Alonso, M.; Barroso-Gonzalez, J.; Alvarez-Losada, S.; Munoz-Fernandez, M.A.; Sanchez-Madrid, F.; Valenzuela-Fernandez, A. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes. J. Cell Sci. 2009, 122, 103-113.
13. Jimenez-Baranda, S.; Gomez-Mouton, C.; Rojas, A.; Martinez-Prats, L.; Mira, E.; Ana Lacalle, R.; Valencia, A.; Dimitrov, D.S.; Viola, A.; Delgado, R.; Martinez, A.C.; Manes, S. Filamin-A regulates actin-dependent clustering of HIV receptors. Nat. Cell Biol. 2007, 9, 838-846.
14. Lehmann, M.J.; Sherer, N.M.; Marks, C.B.; Pypaert, M.; Mothes, W. Actin-and myosin-driven movement of viruses along filopodia precedes their entry into cells. J. Cell. Biol. 2005, 170, 317-325.
15. Harmon, B.; Ratner, L. Induction of the Galpha(q) signaling cascade by the human immunodeficiency virus envelope is required for virus entry. J. Virol. 2008, 82, 9191-9205.
16. Yoder, A.; Yu, D.; Dong, L.; Iyer, S.R.; Xu, X.; Kelly, J.; Liu, J.; Wang, W.; Vorster, P.J.; Agulto, L.; Stephany, D.A.; Cooper, J.N.; Marsh, J.W.; Wu, Y. HIV envelope-CXCR4 signaling activates cofilin to overcome cortical actin restriction in resting CD4 T cells. Cell 2008, 134, 782-792.
17. del Real, G.; Jimenez-Baranda, S.; Mira, E.; Lacalle, R.A.; Lucas, P.; Gomez-Mouton, C.; Alegret, M.; Pena, J.M.; Rodriguez-Zapata, M.; Alvarez-Mon, M.; Martinez, A.C.; Manes, S. Statins inhibit HIV-1 infection by down-regulating Rho activity. J. Exp. Med. 2004, 200, 541-547.
18. Harmon, B.; Campbell, N.; Ratner, L. Role of Abl kinase and the Wave2 signaling complex in HIV-1 entry at a post-hemifusion step. PLoS Pathog. 2010, 6, e1000956.
19. Pontow, S.E.; Heyden, N.V.; Wei, S.; Ratner, L. Actin cytoskeletal reorganizations and coreceptor-mediated activation of rac during human immunodeficiency virus-induced cell fusion. J. Virol. 2004, 78, 7138-7147.
20. Carter, G.C.; Bernstone, L.; Baskaran, D.; James, W. HIV-1 infects macrophages by exploiting an endocytic route dependent on dynamin, Rac1 and Pak1. Virology 2011, 409, 234-250.
21. Komano, J.; Miyauchi, K.; Matsuda, Z.; Yamamoto, N. Inhibiting the Arp2/3 complex limits infection of both intracellular mature vaccinia virus and primate lentiviruses. Mol. Biol. Cell 2004, 15, 5197-5207.
22. Vorster, P.J.; Guo, J.; Yoder, A.; Wang, W.; Zheng, Y.; Xu, X.; Yu, D.; Spear, M.; Wu, Y. LIM kinase 1 modulates cortical actin and CXCR4 cycling and is activated by HIV-1 to initiate viral infection. J. Biol. Chem. 2011, doi:10.1074/jbc.M110.182238
23. Cameron, P.U.; Saleh, S.; Sallmann, G.; Solomon, A.; Wightman, F.; Evans, V.A.; Boucher, G.; Haddad, E.K.; Sekaly, R.P.; Harman, A.N.; Anderson, J.L.; Jones, K.L.; Mak, J.; Cunningham, A.L.; Jaworowski, A.; Lewin, S.R. Establishment of HIV-1 latency in resting CD4+ T cells depends on chemokine-induced changes in the actin cytoskeleton. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 16934-16939.
24. Nishita, M.; Aizawa, H.; Mizuno, K. Stromal cell-derived factor 1alpha activates LIM kinase 1 and induces cofilin phosphorylation for T-cell chemotaxis. Mol. Cell Biol. 2002, 22, 774-783.
25. Nishita, M.; Tomizawa, C.; Yamamoto, M.; Horita, Y.; Ohashi, K.; Mizuno, K. Spatial and temporal regulation of cofilin activity by LIM kinase and Slingshot is critical for directional cell migration. J. Cell. Biol. 2005, 171, 349-359.
26. Wabnitz, G.H.; Nebl, G.; Klemke, M.; Schroder, A.J.; Samstag, Y. Phosphatidylinositol 3-kinase functions as a Ras effector in the signaling cascade that regulates dephosphorylation of the actin-remodeling protein cofilin after costimulation of untransformed human T lymphocytes. J. Immunol. 2006, 176, 1668-1674.
27. Arhel, N.; Genovesio, A.; Kim, K.A.; Miko, S.; Perret, E.; Olivo-Marin, J.C.; Shorte, S.; Charneau, P. Quantitative four-dimensional tracking of cytoplasmic and nuclear HIV-1 complexes. Nat. Methods 2006, 3, 817-824.
28. McDonald, D.; Vodicka, M.A.; Lucero, G.; Svitkina, T.M.; Borisy, G.G.; Emerman, M.; Hope, T.J. Visualization of the intracellular behavior of HIV in living cells. J. Cell. Biol. 2002, 159, 441-452.
29. Valenzuela-Fernandez, A.; Alvarez, S.; Gordon-Alonso, M.; Barrero, M.; Ursa, A.; Cabrero, J.R.; Fernandez, G.; Naranjo-Suarez, S.; Yanez-Mo, M.; Serrador, J.M.; Munoz-Fernandez, M.A.; Sanchez-Madrid, F. Histone deacetylase 6 regulates human immunodeficiency virus type 1 infection. Mol. Biol. Cell 2005, 16, 5445-5454.
30. Wu, Y.; Yoder, A.; Yu, D.; Wang, W.; Liu, J.; Barrett, T.; Wheeler, D.; Schlauch, K. Cofilin activation in peripheral CD4 T cells of HIV-1 infected patients: A pilot study. Retrovirology 2008, 5, 95.
31. Fackler, O.T.; Peterlin, B.M. Endocytic entry of HIV-1. Curr. Biol. 2000, 10, 1005-1008.
32. Daecke, J.; Fackler, O.T.; Dittmar, M.T.; Krausslich, H.G. Involvement of clathrin-mediated endocytosis in human immunodeficiency virus type 1 entry. J. Virol. 2005, 79, 1581-1594.
33. Miyauchi, K.; Kim, Y.; Latinovic, O.; Morozov, V.; Melikyan, G.B. HIV enters cells via endocytosis and dynamin-dependent fusion with endosomes. Cell 2009, 137, 433-444.
34. Bosch, B.; Grigorov, B.; Senserrich, J.; Clotet, B.; Darlix, J.L.; Muriaux, D.; Este, J.A. A clathrin-dynamin-dependent endocytic pathway for the uptake of HIV-1 by direct T cell-T cell transmission. Antivir. Res. 2008, 80, 185-193.
35. Clotet-Codina, I.; Bosch, B.; Senserrich, J.; Fernandez-Figueras, M.T.; Pena, R.; Ballana, E.; Bofill, M.; Clotet, B.; Este, J.A. HIV endocytosis after dendritic cell to T cell viral transfer leads to productive virus infection. Antivir. Res. 2009, 83, 94-98.
36. Marechal, V.; Prevost, M.C.; Petit, C.; Perret, E.; Heard, J.M.; Schwartz, O. Human immunodeficiency virus type 1 entry into macrophages mediated by macropinocytosis. J. Virol. 2001, 75, 11166-11177.
37. Kaksonen, M.; Toret, C.P.; Drubin, D.G. Harnessing actin dynamics for clathrin-mediated endocytosis. Nat. Rev. Mol. Cell. Biol. 2006, 7, 404-414.
38. Robertson, A.S.; Smythe, E.; Ayscough, K.R. Functions of actin in endocytosis. Cell. Mol. Life Sci. 2009, 66, 2049-2065.
39. Conibear, E. Converging views of endocytosis in yeast and mammals. Curr. Opin. Cell Biol. 2010, 22, 513-518.
40. Haller, C.; Fackler, O.T. HIV-1 at the immunological and T-lymphocytic virological synapse. Biol. Chem. 2008, 389, 1253-1560.
41. Jin, J.; Sherer, N.M.; Heidecker, G.; Derse, D.; Mothes, W. Assembly of the murine leukemia virus is directed towards sites of cell-cell contact. PLoS Biol. 2009, 7, e1000163.
42. Feldmann, J.; Schwartz, O. HIV-1 Virological Synapse: Live Imaging of Transmission. Viruses 2010, 2, 1666-1680.
43. Sattentau, Q.J. Retroviruses and the Third Synapse. Viruses 2010, 2, 1008-1010.
44. Arhel, N. Revisiting HIV-1 uncoating. Retrovirology 2010, 7, 96.
45. Arhel, N.J.; Souquere-Besse, S.; Munier, S.; Souque, P.; Guadagnini, S.; Rutherford, S.; Prevost, M.C.; Allen, T.D.; Charneau, P. HIV-1 DNA Flap formation promotes uncoating of the pre-integration complex at the nuclear pore. EMBO J. 2007, 26, 3025-3037.
46. Dismuke, D.J.; Aiken, C. Evidence for a functional link between uncoating of the human immunodeficiency virus type 1 core and nuclear import of the viral preintegration complex. J. Virol. 2006, 80, 3712-3720.
47. Dvorin, J.D.; Malim, M.H. Intracellular trafficking of HIV-1 cores: Journey to the center of the cell. Curr. Top. Microbiol. Immunol. 2003, 281, 179-208.
48. Bukrinskaya, A.; Brichacek, B.; Mann, A.; Stevenson, M. Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J. Exp. Med. 1998, 188, 2113-2125.
49. Wiskerchen, M.; Muesing, M.A. Human immunodeficiency virus type 1 integrase: Effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 1995, 69, 376-386.
50. Peterlin, B.M. Transcription elongation takes central stage: The P-TEFb connection. Cell Cycle 2010, 9, 2933-2934.
51. Brandt, D.T.; Xu, J.; Steinbeisser, H.; Grosse, R. Regulation of myocardin-related transcriptional coactivators through cofactor interactions in differentiation and cancer. Cell Cycle 2009, 8, 2523-2527.
52. Vartiainen, M.K. Nuclear actin dynamics--from form to function. FEBS Lett. 2008, 582, 2033-2040.
53. Zheng, B.; Han, M.; Bernier, M.; Wen, J.K. Nuclear actin and actin-binding proteins in the regulation of transcription and gene expression. FEBS J. 2009, 276, 2669-2685.
54. Wu, R.F.; Gu, Y.; Xu, Y.C.; Mitola, S.; Bussolino, F.; Terada, L.S. Human immunodeficiency virus type 1 Tat regulates endothelial cell actin cytoskeletal dynamics through PAK1 activation and oxidant production. J. Virol. 2004, 78, 779-789.
55. Lopez-Huertas, M.R.; Callejas, S.; Abia, D.; Mateos, E.; Dopazo, A.; Alcami, J.; Coiras, M. Modifications in host cell cytoskeleton structure and function mediated by intracellular HIV-1 Tat protein are greatly dependent on the second coding exon. Nucl. Acid. Res. 2010, 38, 3287-3307.
56. Benkirane, M.; Chun, R.F.; Xiao, H.; Ogryzko, V.V.; Howard, B.H.; Nakatani, Y.; Jeang, K.T. Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem. 1998, 273, 24898-24905.
57. Mahmoudi, T.; Parra, M.; Vries, R.G.; Kauder, S.E.; Verrijzer, C.P.; Ott, M.; Verdin, E. The SWI/SNF chromatin-remodeling complex is a cofactor for Tat transactivation of the HIV promoter. J. Biol. Chem. 2006, 281, 19960-19968.
58. Farrants, A.K. Chromatin remodelling and actin organisation. FEBS Lett. 2008, 582, 2041-2050.
59. Kimura, T.; Hashimoto, I.; Yamamoto, A.; Nishikawa, M.; Fujisawa, J.I. Rev-dependent association of the intron-containing HIV-1 gag mRNA with the nuclear actin bundles and the inhibition of its nucleocytoplasmic transport by latrunculin-B. Genes Cells 2000, 5, 289-307.
60. Audoly, G.; Popoff, M.R.; Gluschankof, P. Involvement of a small GTP binding protein in HIV-1 release. Retrovirology 2005, 2, 48.
61. Sasaki, H.; Nakamura, M.; Ohno, T.; Matsuda, Y.; Yuda, Y.; Nonomura, Y. Myosin-actin interaction plays an important role in human immunodeficiency virus type 1 release from host cells. Proc. Natl. Acad. Sci. U. S. A. 1995, 92, 2026-2030.
62. Müller, B.; Kräusslich, H.-G. Actin-disrupting drugs do not affect the localization of HIV-1 Gag or kinetics of budding. Department of Infectious Diseases, Virology, Heidelberg, Germany, 2011, Unpublished observations.
63. Chukkapalli, V.; Hogue, I.B.; Boyko, V.; Hu, W.S.; Ono, A. Interaction between the human immunodeficiency virus type 1 Gag matrix domain and phosphatidylinositol-(4,5)-bisphosphate is essential for efficient gag membrane binding. J. Virol. 2008, 82, 2405-2417.
64. Tang, C.; Loeliger, E.; Luncsford, P.; Kinde, I.; Beckett, D.; Summers, M.F. Entropic switch regulates myristate exposure in the HIV-1 matrix protein. Proc. Natl. Acad. Sci. U. S. A. 2004, 101, 517-522.
65. Liu, B.; Dai, R.; Tian, C.J.; Dawson, L.; Gorelick, R.; Yu, X.F. Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. J. Virol. 1999, 73, 2901-2908.
66. Rey, O.; Canon, J.; Krogstad, P. HIV-1 Gag protein associates with F-actin present in microfilaments. Virology 1996, 220, 530-534.
67. Shoeman, R.L.; Kesselmier, C.; Mothes, E.; Honer, B.; Traub, P. Non-viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett. 1991, 278, 199-203.
68. Martinez, N.W.; Xue, X.; Berro, R.G.; Kreitzer, G.; Resh, M.D. Kinesin KIF4 regulates intracellular trafficking and stability of the human immunodeficiency virus type 1 Gag polyprotein. J. Virol. 2008, 82, 9937-9950.
69. Swanson, C.M.; Malim, M.H. Retrovirus RNA trafficking: From chromatin to invasive genomes. Traffic 2006, 7, 1440-1450.
70. Gladnikoff, M.; Shimoni, E.; Gov, N.S.; Rousso, I. Retroviral assembly and budding occur through an actin-driven mechanism. Biophys. J. 2009, 97, 2419-2428.
71. Ott, D.E.; Coren, L.V.; Johnson, D.G.; Kane, B.P.; Sowder, R.C., 2nd; Kim, Y.D.; Fisher, R.J.; Zhou, X.Z.; Lu, K.P. Henderson, L.E. Actin-binding cellular proteins inside human immunodeficiency virus type 1. Virology 2000, 266, 42-51.
72. Ott, D.E.; Coren, L.V.; Kane, B.P.; Busch, L.K.; Johnson, D.G.; Sowder, R.C., 2nd; Chertova, E.N.; Arthur, L.O.; Henderson, L.E. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 1996, 70, 7734-7743.
73. Bieniasz, P.D. The cell biology of HIV-1 virion genesis. Cell Host Microbe 2009, 5, 550-558.
74. Carlton, J.G.; Agromayor, M.; Martin-Serrano, J. Differential requirements for Alix and ESCRT-III in cytokinesis and HIV-1 release. Proc. Natl. Acad. Sci. U. S. A. 2008, 105, 10541-10546.
75. Sevrioukov, E.A.; Moghrabi, N.; Kuhn, M.; Kramer, H. A mutation in dVps28 reveals a link between a subunit of the endosomal sorting complex required for transport-I complex and the actin cytoskeleton in Drosophila. Mol. Biol. Cell. 2005, 16, 2301-2312.
76. Karczewski, M.K.; Strebel, K. Cytoskeleton association and virion incorporation of the human immunodeficiency virus type 1 Vif protein. J. Virol. 1996, 70, 494-507.
77. Goila-Gaur, R.; Strebel, K. HIV-1 Vif, APOBEC, and intrinsic immunity. Retrovirology 2008, 5, 51.
78. Kestler, H.W., 3rd; Ringler, D.J.; Mori, K.; Panicali, D.L.; Sehgal, P.K.; Daniel, M.D.; Desrosiers, R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65, 651-662.
79. Geyer, M.; Fackler, O.T.; Peterlin, B.M. Structure-function relationships in HIV-1 Nef. EMBO Rep. 2001, 2, 580-585.
80. Laguette, N.; Bregnard, C.; Benichou, S.; Basmaciogullari, S. Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. Mol. Aspects Med. 2010, 31, 418-433.
81. Arhel, N.J.; Kirchhoff, F. Implications of Nef: Host cell interactions in viral persistence and progression to AIDS. Curr. Top. Microbiol. Immunol. 2009, 339, 147-175.
82. Fackler, O.T.; Luo, W.; Geyer, M.; Alberts, A.S.; Peterlin, B.M. Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions. Mol. Cell 1999, 3, 729-739.
83. Stolp, B.; Reichman-Fried, M.; Abraham, L.; Pan, X.; Giese, S.I.; Hannemann, S.; Goulimari, P.; Raz, E.; Grosse, R.; Fackler, O.T. HIV-1 Nef interferes with host cell motility by deregulation of Cofilin. Cell Host Microbe 2009, 6, 174-186.
84. Haller, C.; Rauch, S.; Fackler, O.T. HIV-1 Nef employs two distinct mechanisms to modulate Lck subcellular localization and TCR induced actin remodeling. PLoS ONE 2007, 2, e1212.
85. Haller, C.; Rauch, S.; Michel, N.; Hannemann, S.; Lehmann, M.J.; Keppler, O.T.; Fackler, O.T. The HIV-1 pathogenicity factor Nef interferes with maturation of stimulatory T-lymphocyte contacts by modulation of N-Wasp activity. J. Biol. Chem. 2006, 281, 19618-19630.
86. Schindler, M.; Rajan, D.; Specht, A.; Ritter, C.; Pulkkinen, K.; Saksela, K.; Kirchhoff, F. Association of Nef with p21-activated kinase 2 is dispensable for efficient human immunodeficiency virus type 1 replication and cytopathicity in ex vivo-infected human lymphoid tissue. J. Virol. 2007, 81, 13005-13014.
87. Stolp, B.; Abraham, L.; Rudolph, J.M.; Fackler, O.T. Lentiviral Nef proteins utilize PAK2-mediated deregulation of cofilin as a general strategy to interfere with actin remodeling. J. Virol. 2010, 84, 3935-3948.
88. Rauch, S.; Pulkkinen, K.; Saksela, K.; Fackler, O.T. Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity. J. Virol. 2008, 82, 2918-2929.
89. Krautkramer, E.; Giese, S.I.; Gasteier, J.E.; Muranyi, W.; Fackler, O.T. Human immunodeficiency virus type 1 Nef activates p21-activated kinase via recruitment into lipid rafts. J. Virol. 2004, 78, 4085-4097.
90. Pulkkinen, K.; Renkema, G.H.; Kirchhoff, F.; Saksela, K. Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts. J. Virol. 2004, 78, 12773-12780.
91. Agopian, K.; Wei, B.L.; Garcia, J.V.; Gabuzda, D. A hydrophobic binding surface on the human immunodeficiency virus type 1 Nef core is critical for association with p21-activated kinase 2. J. Virol. 2006, 80, 3050-3061.
92. Manninen, A.; Hiipakka, M.; Vihinen, M.; Lu, W.; Mayer, B.J.; Saksela, K. SH3-Domain binding function of HIV-1 Nef is required for association with a PAK-related kinase. Virology 1998, 250, 273-282.
93. Renkema, G.H.; Manninen, A.; Saksela, K. Human immunodeficiency virus type 1 Nef selectively associates with a catalytically active subpopulation of p21-activated kinase 2 (PAK2) independently of PAK2 binding to Nck or beta-PIX. J. Virol. 2001, 75, 2154-2160.
94. Rudolph, J.M.; Eickel, N.; Haller, C.; Schindler, M.; Fackler, O.T. Inhibition of T-cell receptor-induced actin remodeling and relocalization of Lck are evolutionarily conserved activities of lentiviral Nef proteins. J. Virol. 2009, 83, 11528-11539.
95. Brown, A.; Wang, X.; Sawai, E.; Cheng-Mayer, C. Activation of the PAK-related kinase by human immunodeficiency virus type 1 Nef in primary human peripheral blood lymphocytes and macrophages leads to phosphorylation of a PIX-p95 complex. J. Virol. 1999, 73, 9899-9907.
96. Vincent, P.; Priceputu, E.; Kay, D.; Saksela, K.; Jolicoeur, P.; Hanna, Z. Activation of p21-activated kinase 2 and its association with Nef are conserved in murine cells but are not sufficient to induce an AIDS-like disease in CD4C/HIV transgenic mice. J. Biol. Chem. 2006, 281, 6940-6954.
97. Nobile, C.; Rudnicka, D.; Hasan, M.; Aulner, N.; Porrot, F.; Machu, C.; Renaud, O.; Prevost, M.C.; Hivroz, C.; Schwartz, O.; Sol-Foulon, N. HIV-1 Nef inhibits ruffles, induces filopodia and modulates migration of infected lymphocytes. J. Virol. 2009, 84, 2282-2293.
98. Haller, C.; Tibroni, N.; Rudolph, J.M.; Grosse, R.; Fackler, O.T. Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse. Eur. J. Cell Biol. 2010, doi:10.1016/j.ejcb.2010.09.010.
99. Friedl, P.; den Boer, A.T.; Gunzer, M. Tuning immune responses: Diversity and adaptation of the immunological synapse. Nat. Rev. Immunol. 2005, 5, 532-545.
100. Arhel, N.; Lehmann, M.; Clauss, K.; Nienhaus, G.U.; Piguet, V.; Kirchhoff, F. The inability to disrupt the immunological synapse between infected human T cells and APCs distinguishes HIV-1 from most other primate lentiviruses. J. Clin. Invest. 2009, 119, 2965-2975.
101. Thoulouze, M.I.; Sol-Foulon, N.; Blanchet, F.; Dautry-Varsat, A.; Schwartz, O.; Alcover, A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 2006, 24, 547-561.
102. Schindler, M.; Munch, J.; Kutsch, O.; Li, H.; Santiago, M.L.; Bibollet-Ruche, F.; Muller-Trutwin, M.C.; Novembre, F.J.; Peeters, M.; Courgnaud, V.; Bailes, E.; Roques, P.; Sodora, D.L.; Silvestri, G.; Sharp, P.M.; Hahn, B.H.; Kirchhoff, F. Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 2006, 125, 1055-1067.
103. Fackler, O.T.; Alcover, A.; Schwartz, O. Modulation of the immunological synapse: A key to HIV-1 pathogenesis? Nat. Rev. Immunol. 2007, 7, 310-317.
104. Pollard, T.D.; Borisy, G.G. Cellular motility driven by assembly and disassembly of actin filaments. Cell 2003, 112, 453-465.
105. Choe, E.Y.; Schoenberger, E.S.; Groopman, J.E.; Park, I.W. HIV Nef inhibits T cell migration. J. Biol. Chem. 2002, 277, 46079-46084.
106. Stein, J.V.; Nombela-Arrieta, C. Chemokine control of lymphocyte trafficking: A general overview. Immunology 2005, 116, 1-12.
107. Phan, T.G.; Gray, E.E.; Cyster, J.G. The microanatomy of B cell activation. Curr. Opin. Immunol. 2009, 21, 258-265.
108. Sugimoto, C.; Tadakuma, K.; Otani, I.; Moritoyo, T.; Akari, H.; Ono, F.; Yoshikawa, Y.; Sata, T.; Izumo, S.; Mori, K. nef gene is required for robust productive infection by simian immunodeficiency virus of T-cell-rich paracortex in lymph nodes. J. Virol. 2003, 77, 4169-4180.
109. Moir, S.; Fauci, A.S. B cells in HIV infection and disease. Nat. Rev. Immunol. 2009, 9, 235-245.
110. Schacker, T. The role of secondary lymphatic tissue in immune deficiency of HIV infection. AIDS 2008, 22, S13-S18.
111. Sourisseau, M.; Sol-Foulon, N.; Porrot, F.; Blanchet, F.; Schwartz, O. Inefficient human immunodeficiency virus replication in mobile lymphocytes. J. Virol. 2007, 81, 1000-1012.
112. Sato, H.; Orenstein, J.; Dimitrov, D.; Martin, M. Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles. Virology 1992, 186, 712-724.
113. Jolly, C.; Kashefi, K.; Hollinshead, M.; Sattentau, Q.J. HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J. Exp. Med. 2004, 199, 283-293.
114. Sowinski, S.; Jolly, C.; Berninghausen, O.; Purbhoo, M.A.; Chauveau, A.; Kohler, K.; Oddos, S.; Eissmann, P.; Brodsky, F.M.; Hopkins, C.; Onfelt, B.; Sattentau, Q.; Davis, D.M. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 2008, 10, 211-219.
115. Xu, W.; Santini, P.A.; Sullivan, J.S.; He, B.; Shan, M.; Ball, S.C.; Dyer, W.B.; Ketas, T.J.; Chadburn, A.; Cohen-Gould, L.; Knowles, D.M.; Chiu, A.; Sanders, R.W.; Chen, K.; Cerutti, A. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 2009, 10, 1008-1017.
116. Qiao, X.; He, B.; Chiu, A.; Knowles, D.M.; Chadburn, A.; Cerutti, A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat. Immunol. 2006, 7, 302-310.
117. Swingler, S.; Zhou, J.; Swingler, C.; Dauphin, A.; Greenough, T.; Jolicoeur, P.; Stevenson, M. Evidence for a pathogenic determinant in HIV-1 Nef involved in B cell dysfunction in HIV/AIDS. Cell Host Microbe 2008, 4, 63-76.
118. Lu, T.C.; He, J.C.; Wang, Z.H.; Feng, X.; Fukumi-Tominaga, T.; Chen, N.; Xu, J.; Iyengar, R.; Klotman, P.E. HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J. Biol. Chem. 2008, 283, 8173-8182.
119. Quaranta, M.G.; Mattioli, B.; Spadaro, F.; Straface, E.; Giordani, L.; Ramoni, C.; Malorni, W.; Viora, M. HIV-1 Nef triggers Vav-mediated signaling pathway leading to functional and morphological differentiation of dendritic cells. FASEB J. 2003, 17, 2025-2036.